SCHEMBL2228327

SCHEMBL2228327

NS(=O)(=O)c1cccc(CNc2cc(Nc3cccc(-c4ccccc4)c3)ncn2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.52
CYP3A4 P08684 3/20 0.52
CYP2C19 P33261 3/20 0.52
ALDH1A1 P00352 2/20 0.52
HSD17B10 Q99714 2/20 0.52
CYP2D6 P10635 2/20 0.52
CLK4 Q9HAZ1 2/20 0.52
JAK3 P52333 2/20 0.51
TNNI3K Q59H18 4/20 0.48
PDE5A O76074 2/20 0.48
CCNT1 O60563 1/20 0.48
CDK9 P50750 1/20 0.48
CYP2C9 P11712 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
MAPK1 P28482 1/20 0.47
HIF1A Q16665 1/20 0.47
EGFR P00533 2/20 0.47
ERBB3 P21860 1/20 0.47
LIPG Q9Y5X9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2226138 0.86 TNNI3K (0.57) JAK3TNNI3KCCNT1CDK9EGFR
SCHEMBL2224438 0.86 TNNI3K (0.57) JAK3TNNI3KPDE5ACCNT1CDK9
SCHEMBL2225416 0.86 NTRK1 (0.56) JAK3TNNI3KPDE5ACCNT1CDK9
SCHEMBL2226716 0.85 PTGES2 (0.47) CYP1A2CYP3A4CYP2C19ALDH1A1HSD17B10
SCHEMBL2224478 0.81 NTRK1 (0.47) JAK3TNNI3KPDE5ACCNT1CDK9
SCHEMBL2225797 0.81 EGFR (0.44) ALDH1A1JAK3TNNI3KCCNT1CDK9
SCHEMBL2225663 0.80 EGFR (0.59) CYP1A2CYP3A4CYP2C19HSD17B10CYP2D6
SCHEMBL2225795 0.80 NTRK1 (0.46) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL2225639 0.80 EGFR (0.44) ALDH1A1JAK3TNNI3KCCNT1CDK9
SCHEMBL2225022 0.80 KDR (0.46) CYP3A4JAK3TNNI3KPDE5ACCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed